Cargando…
Drug Use in Older Adults with Amyotrophic Lateral Sclerosis Near the End of Life
BACKGROUND: Amyotrophic lateral sclerosis (ALS), with its certain prognosis and swift progression, raises concerns regarding the adequacy of pharmacological treatment, including the risk–benefit profiles of prescribed drugs. OBJECTIVE: Our objective was to evaluate the use of prescription drugs over...
Autores principales: | Grande, Giulia, Morin, Lucas, Vetrano, Davide Liborio, Fastbom, Johan, Johnell, Kristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5488113/ https://www.ncbi.nlm.nih.gov/pubmed/28536907 http://dx.doi.org/10.1007/s40266-017-0469-3 |
Ejemplares similares
-
Adequate, questionable, and inadequate drug prescribing for older adults at the end of life: a European expert consensus
por: Morin, Lucas, et al.
Publicado: (2018) -
How many older adults receive drugs of questionable clinical benefit near the end of life? A cohort study
por: Morin, Lucas, et al.
Publicado: (2019) -
The epidemiology of polypharmacy in older adults: register-based prospective cohort study
por: Morin, Lucas, et al.
Publicado: (2018) -
Undertreatment of osteoporosis in the oldest old? A nationwide study of over 700,000 older people
por: Johnell, Kristina, et al.
Publicado: (2009) -
National Indicators for Quality of Drug Therapy in Older Persons: the Swedish Experience from the First 10 Years
por: Fastbom, Johan, et al.
Publicado: (2015)